Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
Noort, S., Zimmermann, M., Reinhardt, D., Cuccuini, W., Pigazzi, M., Smith, J., Ries, R. E., Alonzo, T. A., Hirsch, B., Tomizawa, D., Locatelli, F., Gruber, T. A., Raimondi, S., Sonneveld, E., Cheuk, D. K., Dworzak, M., Stary, J., Abrahamsson, J., Arad-Cohen, N., Czogala, M., De Moerloose, B., Hasle, H., Meshinchi, S., van den Heuvel-Eibrink, M., Zwaan, C. M.
American Society of Hematology (ASH)
Published 2018
American Society of Hematology (ASH)
Published 2018
Publication Date: |
2018-10-12
|
---|---|
Publisher: |
American Society of Hematology (ASH)
|
Print ISSN: |
0006-4971
|
Electronic ISSN: |
1528-0020
|
Topics: |
Biology
Medicine
|
Keywords: |
Pediatric Hematology, Myeloid Neoplasia, Clinical Trials and Observations
|
Published by: |